Lifestyle effects on hematopoiesis and atherosclerosis

Matthias Nahrendorf1, Filip K Swirski1

  • 1From the Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston. mnahrendorf@mgh.harvard.edu fswirski@mgh.harvard.edu.

Circulation Research
|February 28, 2015
PubMed

Insights

Lifestyle factors like diet and stress impact chronic inflammatory diseases by altering immune cell production. This study explores how these factors influence hematopoietic processes, potentially affecting atherosclerosis risk.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Hematology

Background:

  • Chronic inflammatory diseases, such as atherosclerosis, are influenced by lifestyle factors including diet, exercise, stress, and sleep.
  • Psychosocial stress and poor diet exacerbate cardiovascular disease, while exercise and good sleep habits are protective.
  • The role of inflammation-associated leukocyte production in mediating lifestyle effects on atherosclerosis is under investigation.

Purpose of the Study:

  • To investigate how lifestyle factors influence the molecular and cellular mechanisms of hematopoiesis.
  • To explore the hypothesis that lifestyle can alter hematopoietic topography, shifting immune cell production.
  • To understand the impact of these changes on the macrophage supply chain and atherosclerosis progression.

Main Methods:

  • The study focuses on exploring the mechanistic links between lifestyle modifiers and hematopoiesis.
  • It examines how external factors influence progenitor-extrinsic and intrinsic communication nodes.
  • The research investigates neuroimmune and immunometabolic axes in relation to immune cell production.

Main Results:

  • Lifestyle factors may rearrange hematopoietic topography, diverting immune cell production from bone marrow to periphery.
  • This shift can lead to quantitative and qualitative changes in the macrophage supply chain.
  • Altered macrophage number and phenotype in lesions are potential consequences.

Conclusions:

  • Inflammation-associated leukocyte production is proposed as a key mediator of lifestyle effects on atherosclerosis.
  • Future therapeutics could target the hematopoietic tree's output and location to mitigate atherosclerosis risk.
  • Public health policies should consider these lifestyle-hematopoiesis interactions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
8.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K